Literature DB >> 15374839

Contributions of high mobility group box protein in experimental and clinical acute lung injury.

Hiroshi Ueno1, Tomoyuki Matsuda, Satoru Hashimoto, Fumimasa Amaya, Yoshihiro Kitamura, Masaki Tanaka, Atsuko Kobayashi, Ikuro Maruyama, Shingo Yamada, Naoki Hasegawa, Junko Soejima, Hidefumi Koh, Akitoshi Ishizaka.   

Abstract

This study was performed to examine the putative role of high mobility group box (HMGB) protein in the pathogenesis of acute lung injury (ALI). Observations were made (1) in 21 patients who were septic with ALI and 15 patients with normal lung function and (2) in a mouse model 24 hours after intratracheal instillation of lipopolysaccharide (LPS). The concentrations of HMGB1 were increased in plasma and lung epithelial lining fluid of patients with ALI and mice instilled with LPS. LPS-induced ALI was mitigated by anti-HMGB1 antibody. Although this protein was not detected in the plasma of control humans or mice, the concentrations of HMGB1 in lung epithelial lining fluid or in bronchoalveolar lavage fluid were unexpectedly high. The nuclear expression of HMGB1 was apparent in epithelial cells surrounding terminal bronchioles in normal mice, whereas its nuclear and cytoplasmic expression was observed in alveolar macrophages in LPS-instilled mice. Lung instillation of HMGB2 did not cause as much inflammation as HMGB1. Extracellular HMGB1 may play a key role in the pathogenesis of clinical and experimental ALI. However, its expression in normal airways is noteworthy and suggests that it also plays a physiologic role in the lung.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15374839     DOI: 10.1164/rccm.200402-188OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  149 in total

1.  Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation.

Authors:  Te I Weng; Hsiao Yi Wu; Chia Wei Kuo; Shing Hwa Liu
Journal:  Intensive Care Med       Date:  2011-01-29       Impact factor: 17.440

2.  High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy.

Authors:  Yoko Oyama; Teruto Hashiguchi; Noboru Taniguchi; Salunya Tancharoen; Tomonori Uchimura; Kamal K Biswas; Ko-Ichi Kawahara; Takao Nitanda; Yoshihisa Umekita; Martin Lotz; Ikuro Maruyama
Journal:  Lab Invest       Date:  2010-03-15       Impact factor: 5.662

3.  The effect of sRAGE-Fc fusion protein attenuates inflammation and decreases mortality in a murine cecal ligation and puncture model.

Authors:  Su Jin Jeong; Beom Jin Lim; Sungha Park; Donghoon Choi; Hye Won Kim; Nam Su Ku; Sang Hoon Han; Chang Oh Kim; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  Inflamm Res       Date:  2012-07-10       Impact factor: 4.575

Review 4.  Post-translational modifications of high mobility group box 1 and cancer.

Authors:  Seidu A Richard; Yuanyuan Jiang; Lu Hong Xiang; Shanshan Zhou; Jia Wang; Zhaoliang Su; Huaxi Xu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

5.  Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice.

Authors:  Konstantin Tsoyi; Hwa Jin Jang; Irina Tsoy Nizamutdinova; Young Min Kim; Young Soo Lee; Hye Jung Kim; Han Geuk Seo; Jae Heun Lee; Ki Churl Chang
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 6.  The inflammatory response to cell death.

Authors:  Kenneth L Rock; Hajime Kono
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

7.  Caging a Beast in the Inflammation Arena: Use of Chinese Medicinal Herbs to Inhibit a Late Mediator of Lethal Sepsis, HMGB1.

Authors:  Shu Zhu; Wei Li; Jianhua Li; Andrew E Sama; Haichao Wang
Journal:  Int J Clin Exp Med       Date:  2008-01-20

8.  The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury.

Authors:  Hiroyuki Seki; Koichi Fukunaga; Makoto Arita; Hiroyuki Arai; Hiroki Nakanishi; Ryo Taguchi; Taku Miyasho; Rina Takamiya; Koichiro Asano; Akitoshi Ishizaka; Junzo Takeda; Bruce D Levy
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

Review 9.  Cell Death in the Lung: The Apoptosis-Necroptosis Axis.

Authors:  Maor Sauler; Isabel S Bazan; Patty J Lee
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

Review 10.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.